Search

Your search keyword '"Fukui, Yasutaka"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Fukui, Yasutaka" Remove constraint Author: "Fukui, Yasutaka" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
48 results on '"Fukui, Yasutaka"'

Search Results

1. Quantification of escape from X chromosome inactivation with single-cell omics data reveals heterogeneity across cell types and tissues

3. DOCK2 is involved in the host genetics and biology of severe COVID-19

5. The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force

8. Multiple cavitary pulmonary metastases from pancreatic cancer diagnosed using transbronchial lung cryobiopsy.

9. Risk factors for 30-day mortality in patients with pneumonia who receive appropriate initial antibiotics: an observational cohort study

10. Comparative Study of Three Commercial Blood (1→3)-β-D-glucan Detection Reagents for Invasive Mycosis

12. Epidermal growth factor receptor mutation‐positive advanced lung adenocarcinoma presenting with acute respiratory failure diagnosed by thin bronchoscope through transnasal route under high‐concentration oxygen mask

13. Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population

15. DOCK2 is involved in the host genetics and biology of severe COVID-19

16. Age-Dependent Reduction in Neutralization against Alpha and Beta Variants of BNT162b2 SARS-CoV-2 Vaccine-Induced Immunity

17. Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Emerging Variants

22. SARS‐CoV‐2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID‐19

24. Functional and quantitative evaluation of BNT162b2 SARS-CoV-2 vaccine-induced immunity

25. Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan

26. Association between high serum favipiravir concentrations and drug-induced liver injury

27. A case of COVID-19 diagnosed with favipiravir-induced drug fever based on a positive drug-induced lymphocyte stimulation test

28. Pembrolizumab and Pemetrexed for Older Patients With Nonsquamous NSCLC and Programmed Cell Death-Ligand 1 Tumor Proportion Scores of Less Than 50%

30. Dynamics of neutralizing antibody responses in acute-phase COVID-19: A potential relationship between disease progression and rapid neutralizing antibody response

31. SARS-CoV-2 RNAemia with higher nasopharyngeal viral load is strongly associated with severity and mortality in patients with COVID-19

32. Transmissibility of COVID-19 depends on the viral load around onset in adult and symptomatic patients

33. Monitoring of viral load by RT-PCR caused decision making to continue ECMO therapy for a patient with COVID-19

34. Evaluation of SARS-CoV-2 Neutralizing Antibodies Using a Vesicular Stomatitis Virus Possessing SARS-CoV-2 Spike Protein

35. Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein

36. Viral load dynamics in transmissible symptomatic patients with COVID-19

37. Report on cause investigation and countermeasure of leakage trace from the drum

38. ドラム缶からの漏えい跡原因調査及び対策に係る報告書

39. DOCK2is involved in the host genetics and biology of severe COVID-19

42. 核燃料施設の解体技術開発; 旧JWTF廃止措置に係る解体工法の検討

43. 重水臨界実験装置(DCA)平成25年度廃止措置に関する解体実績報告

44. 炉内構造物及び燃料デブリの切断技術開発; プラズマジェット切断技術の適用性試験

47. 非正規雇用から正規雇用への移動における企業規模間格差――二重&#27083...

48. SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19.

Catalog

Books, media, physical & digital resources